-
Public Health Impact of 25 Years of Pneumococcal Conjugate Vaccination in Children 5 Years Old: A Modeling Analysis
Sep 9, 2025, 16:22 PM -
How Are Clinical Trials for Breast Cancer Treatments Currently Being Designed? A Clinical Trial Database Analysis
Sep 9, 2025, 16:22 PM -
Healthcare Costs in Older Adults: XGBoost, NNA, and Logit
Sep 9, 2025, 16:22 PM -
Understanding Reimbursement and Access Policies for Immunoglobulins and Other Plasma-Derived Medicinal Products Across Europe
Sep 9, 2025, 16:22 PM -
Increased Trends of Self-Optimized Submissions to NICE
Sep 9, 2025, 16:22 PM -
Impact of Maternal Vaccination Strategy on RSV-Related Hospital Burden Among Infants Aged Less Than One Year in France: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Role of Technical Engagement in NICE Process Under Proportionate Approach to Technology Appraisals
Sep 9, 2025, 16:22 PM -
Demonstrating the Importance of Modeling Rapid Cancer Progression in Screening Evaluations
Sep 9, 2025, 16:22 PM -
Exploring Nordic Real-World Evidence Sources for a PICO Assessment of a Hypothetical Oncology Drug and Medical Device Product
Sep 9, 2025, 16:22 PM -
Procalcitonin-Guided Antimicrobial Stewardship for Sepsis and Lower Respiratory Tract Infections: A Budget Impact Analysis for the Perspective of the Patients in India
Sep 9, 2025, 16:22 PM -
System-Level Economic Impact of a Combination Influenza-COVID-19 Vaccine vs. Standalone Vaccinations in the United Kingdom
Sep 9, 2025, 16:22 PM -
Real-World Evidence in European Orphan Drug Submissions and the Impact on Reimbursement Success
Sep 9, 2025, 16:22 PM -
Evaluating the Cost-Effectiveness of Adjuvanted Influenza Vaccine in the Older Adult Population in the Netherlands
Sep 9, 2025, 16:22 PM -
Exploring the Integration of Artificial Intelligence in Health Economic, Systematic Review, and Evidence Synthesis Methods: A Scoping Review of NICE Technology Appraisal and Assessment Reports
Sep 9, 2025, 16:22 PM -
Trends in Vaccination at Pharmacies by Race Among Medicaid Recipients: A Claims Analysis
Sep 9, 2025, 16:22 PM -
Public Health Impact of Herpes Zoster Vaccination in Immunocompromised Adults Aged 18-49 Years in the United Kingdom
Sep 9, 2025, 16:22 PM -
Indirect Comparison of Tarlatamab vs. Chemotherapy (CTx) in Patients With Previously Treated, Platinum-Refractory, or Resistant Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
Improving Data Quality in Oncology Electronic Health Record (EHR)-Derived Databases for Research and Regulatory Decision Making
Sep 9, 2025, 16:22 PM -
Cost of Adverse Events With the Bruton Tyrosine Kinase Inhibitors Ibrutinib and Acalabrutinib in the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia in Brazil
Sep 9, 2025, 16:22 PM -
Matching-Adjusted Indirect Comparisons (MAICs) and Network Meta-Analyses (NMAs) of the Oral Small-Molecule Chaperone Migalastat vs. Intravenous Enzyme Replacement Therapies (ERTs) for Clinical Measures in Fabry Disease
Sep 9, 2025, 16:22 PM
